1. Home
  2. XXII

as 07-01-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

Founded: 1998 Country:
United States
United States
Employees: N/A City: WILLIAMSVILLE
Market Cap: 9.0M IPO Year: N/A
Target Price: $80.00 AVG Volume (30 days): 727.1K
Analyst Decision: Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -91.10 EPS Growth: N/A
52 Week Low/High: $0.58 - $110.24 Next Earning Date: 08-12-2024
Revenue: $16,711,000 Revenue Growth: -58.62%
Revenue Growth (this year): 6.19% Revenue Growth (next year): 2.98%

XXII Daily Stock ML Predictions

Stock Insider Trading Activity of 22nd Century Group Inc. (XXII)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
FIRESTONE LAWRENCE XXII Chief Executive Officer May 30 '24 Buy $1.09 9,000 $9,828.90 15,250 SEC Form 4
Arno Andrew XXII Director Jan 5 '24 Buy $0.17 100,000 $17,490.00 100,000 SEC Form 4
FIRESTONE LAWRENCE XXII Chief Executive Officer Jan 4 '24 Buy $0.17 100,000 $17,360.00 100,000 SEC Form 4

Share on Social Networks: